Clinical Trial

CINSARC Signature and Correlation With Hemotherapy Efficacy in Soft-tissue Sarcomas. A Biomarker Study.

Study acronym: NEOSarcomics
Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective observational biomarker study including patients with non-metastatic, soft-tissue sarcomas (STS) for whom neoadjuvant chemotherapy is considered as the best option by the multidisciplinary sarcoma team of one of the participating centers.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2016-05-27; most recent amendment 2025-11-24.
Status change: Not Yet Recruiting → Recruiting 2017-09-29
Trial Details
NCT Number NCT02789384
Lead Sponsor Institut Bergonié
Collaborators: National Cancer Institute, France, Ministry of Health, France
Conditions Soft-tissue Sarcomas
Enrollment 205 participants
Start Date 2016-06
Primary Completion 2026-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-02